The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for B König


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
NTS2-selective neurotensin mimetics with tetrahydrofuran amino acids.EBI
University of Regensburg
Flavonoid derivatives as selective ABCC1 modulators: Synthesis and functional characterization.EBI
University of Regensburg
Benzanilide-Biphenyl Replacement: A Bioisosteric Approach to Quinoline Carboxamide-Type ABCG2 Modulators.EBI
University of Regensburg
Photoswitchable Probes of Oxytocin and Vasopressin.EBI
University of Regensburg
Difluoromethyl-1,3,4-oxadiazoles Are Selective, Mechanism-Based, and Essentially Irreversible Inhibitors of Histone Deacetylase EBI
University of Bonn
Importance of Binding Site Hydration and Flexibility Revealed When Optimizing a Macrocyclic Inhibitor of the Keap1-Nrf2 Protein-Protein Interaction.EBI
Uppsala University
Tariquidar-related triazoles as potent, selective and stable inhibitors of ABCG2 (BCRP).EBI
University of Regensburg
N(ω)-Carbamoylation of the Argininamide Moiety: An Avenue to Insurmountable NPY Y1 Receptor Antagonists and a Radiolabeled Selective High-Affinity Molecular Tool ([(3)H]UR-MK299) with Extended Residence Time.EBI
Cnrs/Ipbs (Institut De Pharmacologie Et Biologie Structurale)
Tariquidar-Related Chalcones and Ketones as ABCG2 Modulators.EBI
Universidad Nacional De Colombia-Sede Bogot£
Substituted tetrazolo[1,5-a]pyrazines as ROR-gamma inhibitorsBDB
Merck Patent